Stock News and Filings Feed


Add GEN
to your dashboard

GeneNews Announces Q2-2017 Financial Results & Provides Progress Update

2017-08-15 prnewswire
TORONTO, Aug. 15, 2017 /PRNewswire/ - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today announced operational and financial results for the three-month period ended June 30, 2017, and provided a progress update on its business.

GeneNews Announces Extension of Warrant Exercise Incentive Program

2017-07-14 prnewswire
TORONTO, July 14, 2017 /PRNewswire/ - GeneNews Limited ("GeneNews" or the "Company") (TSX:GEN) announces that it will extend the deadline for participating in its previously announced warrant exercise incentive program (the "Program") from July 14, 2017 until August 31, 2017.  The Incentive Program is intended to encourage the early exercise of up to 12,466,238 outstanding and unlisted warrants (the "Warrants").

GeneNews Announces Issuance of Common Shares In Lieu Of Cash Payments to Participating Members of its Board of Directors

2017-07-14 prnewswire
TORONTO, July 14, 2017 /PRNewswire/ - At its annual and special meeting of shareholders held on June 29, 2017, GeneNews Limited ("GeneNews" or the "Company") (TSX:GEN) sought and received disinterested shareholder approval for the issuance of common shares from treasury (the "Common Shares") to certain members of its Board (the "Participating Directors") who, in order to assist the Company address its payment obligations while preserving its cash resources, were considering accepting payment of up-to the total amount of fees and expenses earned and unpaid at the time of the Meeting, through the issuance of Common Shares.

Daily Coverage on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies

2017-06-19 accesswire
LONDON, UK / ACCESSWIRE / June 19, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select stocks with the Medical Diagnostics & Research industry and that trades on the Toronto Exchanges. This Morning, our team has regrouped these stocks for study: Spectral Medical, ProMIS Neurosciences, GeneNews, and Novadaq Technologies.

GeneNews Early Warrant Exercise Incentive Program

2017-05-30 prnewswire
TORONTO, May 30, 2017 /PRNewswire/ - GeneNews Limited ("GeneNews" or the "Corporation") (TSX:GEN) announces a warrant exercise incentive program (the "Program") designed to encourage the early exercise of its 12,466,238 outstanding and unlisted warrants (the "Warrants").

Research Reports Initiated on Healthcare Stocks: Spectral Medical, ProMIS Neurosciences, GeneNews, and Sernova

2017-05-01 accesswire
LONDON, UK / ACCESSWIRE / May 1, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Medical Diagnostics & Research industry. Companies recently under review include Spectral Medical, ProMIS Neurosciences, GeneNews, and Sernova.

GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests

2017-03-17 devicespace
TORONTO, March 16, 2017 /PRNewswire/ - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") announced today that it has signed an agreement with a large, multi-specialty physician group in the American Midwest for use of its cancer diagnostic tests. The contract represents the second partnership agreement with a U.S. healthcare services group and will mark the introduction of GeneNews' BreastSentry® diagnostic test to the U.

GeneNews Announces Change In Auditor

2017-03-07 devicespace
TORONTO, March 7, 2017 /CNW/ - GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") announced today that its board of directors (the "Board") has approved a change of the Company's auditor. The Board has accepted the resignation of Ernst & Young LLP ("EY") as GeneNews' auditor effective as of today and is in the final stages of engaging a middle market, U.S.-based independent registered public accounting firm.

GeneNews Announces Q3-2016 Financial Results And Provides Corporate Update

2016-11-11 devicespace
TORONTO, Nov. 11, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month period ended September 30, 2016.

GeneNews Provides Update On GEM And Alumina Financings

2016-10-03 devicespace
TORONTO, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Further to its press releases issued on April 28, June 9 and July 26, 2016, GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) provided an update today on its financing activities.

Most actively traded companies on the TSX

2016-09-19 winnipegfreepress
Bombardier Inc. (TSX:BBD.B). Aerospace, rail equipment. Down nine cents, or 4.89 per cent, to $1.75 on 7.6-million shares.

GeneNews And Announce Partnership In Early Cancer Diagnostics

2016-09-19 devicespace
TORONTO, Sept. 19, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) today announced it has entered into a partnership agreement with NueHealth, LLC, a privately owned company that delivers value-based healthcare solutions and connects patients directly to physicians through integrated provider networks, or IPNs.

GeneNews Closes Private Placement For Approximately $1.6 Million

2016-09-02 devicespace
TORONTO, Sept. 02, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) today announced that it has accepted subscriptions for a non-brokered private placement offering (“Private Placement”) of 9,794,203 units ("Units"), at a price of $0.16 per Unit.  Each Unit is comprised of one common share ("Common Share") and one-quarter of one common share purchase warrant (each whole common share purchase warrant, a "Warrant").

GeneNews Provides Financing Update

2016-07-27 devicespace
TORONTO, July 26, 2016 (GLOBE NEWSWIRE) -- Further to its press releases issued on December 7, 2015 and June 9, 2016, GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) provided an update today on its financing activities.

GeneNews Announces Filing Of Q1-2016 Financial Results

2016-06-15 devicespace
TORONTO, June 15, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today reported operational and financial results for the three-month period ended March 31, 2016.  The full filing can be viewed on www.sedar.com.

Most actively traded companies on the TSX

2016-04-01 winnipegfreepress
Lake Shore Gold Corp. (TSX:LSG). Miner. Up one cent, or 0.53 per cent, to $1.90 on 29.6 million shares.

Most actively traded companies on the TSX

2016-03-31 winnipegfreepress
GeneNews Ltd. (TSX:GEN). Health-care. Up six cents, or 52.17 per cent, to 17.5 cents on 9.1 million shares.

Most actively traded companies on the TSX

2016-03-28 winnipegfreepress
Acerus Pharmaceuticals Corp. (TSX:ASP). Drug manufacturer. Up eight cents, or 84.21 per cent, to 17.5 cents on 6.3 million shares.

GeneNews Files Management Cease Trade Order

2016-03-17 devicespace
TORONTO, March 17, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited (“GeneNews” or the “Company”) (GEN.TO) confirmed today that, further to its press release of March 14, 2016, the filing of its annual financial statements, management’s discussion and analysis, annual information form and the related officer certifications for the financial year ended December 31, 2015 (collectively, the “Annual Filings”) will be delayed beyond the filing deadline of March 30, 2016.

BRIEF-GeneNews Ltd says filing of annual statement to delay

2016-03-17 reuters
* GeneNews Ltd says filing of its annual statements for year ended Dec 31, 2015 will be delayed beyond filing deadline of March 30, 2016

Most actively traded companies on the TSX

2016-03-14 winnipegfreepress
Niko Resources Ltd. (TSX:NKO). Oil and gas. Up 15 cents, or 53.57 per cent, to 43 cents on 15.2 million shares.